XML 28 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Convertible Preferred Stock, Common Stock and Stockholders' Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2013
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity under the 2007 Plan and 2013 Plan is as follows:

 

     Shares      Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Term
(Years)
     Aggregate
Intrinsic
Value
 

Outstanding at December 31, 2012

     123,250       $ 0.40         7.84       $ 578   

Granted

     501,500       $ 9.39         9.88         —     

Exercised

     —           —           —           —     

Canceled/Forfeited

     —           —           —           —     

Outstanding at December 31, 2013

     624,750       $ 7.61         8.41       $ 869,490   

Exercisable at December 31, 2013 (1)

     90,540       $ 0.39         5.01       $ 638,881   

Vested or expected to vest at December 31, 2013

     624,750       $ 7.61         8.41       $ 869,490   

 

(1) Includes awards with early exercise provisions that permit optionee to exercise unvested options.
Summary of Estimated Fair Value of Stock Option Award Granted

The estimated fair value of each option award granted was determined on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions for options grants during the three years ended December 31, 2013:

 

     Year Ended December 31,
     2013    2012      2011

Stock Options

        

Risk free interest rate

   1.75% - 1.8%      —         2.33%

Expected option term

   6.0 years      —         5.0 years

Expected volatility of common stock

   70.8% - 79.4%      —         80.0%

Expected dividend yield

   —%      —         —%
Summary of Non-Cash Share-Based Compensation Expense

The Company recognized non-cash stock-based compensation expense to employees and directors in its research and development and its general and administrative functions as follows:

 

     Year Ended December 31,      Period from
January 29,
2007
(Inception) to
December 31,
 
     2013      2012      2011      2013  

Research and development

   $ 39,638       $ 10,004       $ 15,360       $ 93,435   

General and administrative

     106,328         2,501         7,345         142,243   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation expense

   $ 145,966       $ 12,505       $ 22,705       $ 235,678   
  

 

 

    

 

 

    

 

 

    

 

 

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following at December 31, 2013 and 2012:

 

     December 31,  
     2013      2012  

Conversion of preferred stock

     —           2,439,002   

Stock options issued and outstanding

     624,750         123,250   

Authorized for future option grants

     8,500         —     

Warrants for convertible preferred stock

     —           14,000   

Warrants for common stock

     106,000         —     

Authorized for Employee Stock Purchase Plan

     330,000         —     
  

 

 

    

 

 

 

Total common stock reserved for future issuance

     1,069,250         2,576,252